We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$851B
AUM Growth
+$80.9B
Cap. Flow
+$19.9B
Cap. Flow %
2.34%
Top 10 Hldgs %
25.93%
Holding
4,889
New
83
Increased
3,362
Reduced
611
Closed
132

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.18B
2
AAPL icon
Apple
AAPL
+$1.11B
3
AVGO icon
Broadcom
AVGO
+$562M
4
AMZN icon
Amazon
AMZN
+$553M
5
PANW icon
Palo Alto Networks
PANW
+$485M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Healthcare 13.33%
3 Financials 12.09%
4 Consumer Discretionary 10.85%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBX
3826
DELISTED
Unity Biotechnology
UBX
$322K ﹤0.01%
126,108
+3,125
+3% +$8.25K
NPCE icon
3827
Neuropace
NPCE
$439M
$321K ﹤0.01%
71,515
AAMC
3828
DELISTED
Altisource Asset Management Corp
AAMC
$319K ﹤0.01%
9,642
-1,619
-14% -$74.9K
GATE
3829
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$318K ﹤0.01%
30,676
+171
+0.6% +$1.75K
CKPT
3830
DELISTED
Checkpoint Therapeutics
CKPT
$318K ﹤0.01%
128,587
+56,997
+80% +$156K
VIRX
3831
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$316K ﹤0.01%
224,438
ORKA
3832
Oruka Therapeutics
ORKA
$5.82B
$316K ﹤0.01%
12,970
ZFOX
3833
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$315K ﹤0.01%
315,333
+49,633
+19% +$55K
LITS
3834
Lite Strategy Inc
LITS
$32.8M
$315K ﹤0.01%
47,833
-3
-0% -$19
TIL icon
3835
Instil Bio
TIL
$48.3M
$314K ﹤0.01%
28,529
-32,223
-53% -$394K
AIRT icon
3836
Air T
AIRT
$75.5M
$313K ﹤0.01%
12,482
-2,519
-17% -$64.6K
PASG icon
3837
Passage Bio
PASG
$14.4M
$312K ﹤0.01%
16,596
CELL
3838
DELISTED
PhenomeX Inc. Common Stock
CELL
$312K ﹤0.01%
636,160
-597,410
-48% -$489K
BIOR
3839
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$311K ﹤0.01%
8,081
+3,672
+83% +$130K
SLAM
3840
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$310K ﹤0.01%
29,043
CYT
3841
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$309K ﹤0.01%
119,032
MBIO icon
3842
Mustang Bio
MBIO
$4.32M
$309K ﹤0.01%
995
+172
+21% +$43.2K
LPTH icon
3843
Lightpath Technologies
LPTH
$651M
$309K ﹤0.01%
228,684
MKUL
3844
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$308K ﹤0.01%
131,676
+44,920
+52% +$83.5K
USCT
3845
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
$308K ﹤0.01%
29,046
NAMS icon
3846
NewAmsterdam Pharma
NAMS
$3.25B
$306K ﹤0.01%
25,768
+7,209
+39% +$95.6K
GGRP
3847
Glimpse Group
GGRP
$18.8M
$305K ﹤0.01%
85,806
ASRV icon
3848
AmeriServ Financial
ASRV
$77.5M
$305K ﹤0.01%
120,070
BWMX icon
3849
Betterware México
BWMX
$634M
$305K ﹤0.01%
23,570
MRDN
3850
Meridian Holdings Inc
MRDN
$143M
$303K ﹤0.01%
9,801

Similar funds

Geode Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
  • Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
  • Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
  • Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
  • Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
  • Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.